Skip to content
Screener

Xencor XNCR Accrued Expenses

Accrued Expenses at other companies

Amgen logo
AmgenAMGN
$17.19B+14.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$2.97B
Janux Therapeutics logo
Janux TherapeuticsJANX
$19.51M+21.7%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$6.08M+22.4%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$32.07M-10.8%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$880.67K+20.3%

Other financials

Income statement

See full
Revenue$51.2M+17.5%
Operating income-$37.1M-11.7%
Net income-$21.7M+29.5%
EPS (diluted)-$0.29+29.3%

Balance sheet

See full
Cash & equivalents$44.7M+0.5%
Total debt$170.1M-20.1%
Total equity$503.2M-18.9%
Total assets$725.0M-17.6%

Cash flow

See full
Operating cash flow-$55.7M-53.0%
CapEx$538.0K+40.5%
Free cash flow-$56.2M-52.9%

Valuation

See full
Market cap$1.6B+221%
Enterprise value$1.73B+159%
P/S15.3×+11.9×

Profitability

See full
Operating margin-205.8%-2,501pp
Net margin-155.6%+78.8pp
FCF margin-198.4%-1,485pp

Returns & leverage

See full
Return on equity-29.1%+0.2pp
Debt / equity0.3×0.0×
Current ratio6.4×+1.1×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The source filing: Xencor’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:02 PM EDT
Fiscal quarter
Q4 FY2028
Calendar quarter
Q4 2028
Accession
0001326732-26-000056
Line itemJune 30,2026December 31,2025
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$12,648$10,828
Accrued expenses36,44634,960
Income tax payable1,4963,589
Lease liabilities3,9173,263
Liabilities related to the sales of future royalties27,35843,267
Total current liabilities81,86595,907

Item 1. Financial Statements

FAQ

What is Xencor's accrued expenses?
Xencor (XNCR) reported accrued expenses of $36.45M in Q2 2026.
How has Xencor's accrued expenses changed year-over-year?
Xencor's accrued expenses increased by 52.6% year-over-year, from $23.88M to $36.45M.
What is the long-term trend for Xencor's accrued expenses?
Over 5 years (2020 to 2025), Xencor's accrued expenses has grown at a 14.7% compound annual growth rate (CAGR), from $17.6M to $34.96M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Xencor's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude